Stay updated on CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Sign up to get notified when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.

Latest updates to the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page
- Check2 days agoChange DetectedThe displayed site revision updates from v3.7.2 to v3.8.0, with the study record content unchanged.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA site-wide NIH notice says federal agencies are transitioning from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.8%

- Check30 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry, Revision: v3.7.0, was added to the record history and the previous Revision: v3.6.6 entry was removed. This reflects an update to the documentation version without altering the study data shown on the page.SummaryDifference0.1%

- Check65 days agoChange DetectedThe history log now shows a new latest revision (v3.6.6) replacing the previous v3.6.5, indicating an internal update to the page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe Study Record History page shows a visual refresh with a revised layout and color-coded status areas. The underlying version list and textual changes appear unchanged, indicating a UI update rather than content updates.SummaryDifference0.1%

Stay in the know with updates to CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Enter your email address, and we'll notify you when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.